RP Cure Tracker

Trials / NCT02926092

Observational Natural History Study of Autosomal Dominant Retinitis Pigmentosa (adRP)

Terminated Observational Natural history / observational

Why it stopped: Development of SHP630 was discontinued based on lack of preclinical efficacy.

Sponsor
Shire
Treatment
Observation
Gene
Not stated
Conditions
Retinitis Pigmentosa
Ages
Any to no upper limit
Enrollment
1 participants
Started
2017-03-13
Main results expected
2017-04-13
Results posted
Not yet
Record last updated
2021-03-17

What the study is testing

The purpose of this study is to gain an understanding of how adRP progresses over time in patients with misfolded rod opsin mutations.

Where it runs

United States (1)

Open on ClinicalTrials.gov for contacts and eligibility